Characterization and bioactivity of self-assembled anti-angiogenic chondroitin sulfate-ES2-AF nanoparticle conjugate

References

• Novoa-CarballalRPerez-MartinRBlancoMBy-products of Scyliorhinus canicula, Prionace glauca and Raja clavata: A valuable source of predominantly 6S sulfated chondroitin sulfateCarbohydr Polym2017157313710.1016/j.carbpol.2016.09.05027987932
   PubMedGoogle Scholar
• YamadaSSugaharaKPotential therapeutic application of chondroitin sulfate/dermatan sulfateCurr Drug Discov Technol20085428930119075609
   PubMedGoogle Scholar
• ZhangJSImaiTSuenagaAOtagiriMMolecular-weight-dependent pharmacokinetics and cytotoxic properties of cisplatin complexes prepared with chondroitin sulfate A and CInt J Pharm20022401–2233112062498
   PubMedGoogle Scholar
• OnishiHMatsuyamaMConjugate between chondroitin sulfate and prednisolone with a glycine linker: preparation and in vitro conversion analysisChem Pharm Bull (Tokyo)201361990291223995354
   PubMed Web of Science ®Google Scholar
• LoYLSungKHChiuCCWangLFChemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene deliveryMol Pharm201310266467610.1021/mp300432s23281918
   PubMed Web of Science ®Google Scholar
• Tjin Tham SjinRMSatchi-FainaroRBirsnerAERamanujamVMFolkmanJJavaherianKA 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activityCancer Res20056593656366310.1158/0008-5472.CAN-04-183315867360
   PubMedGoogle Scholar
• WickstromSAAlitaloKKeski-OjaJAn endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cellsJ Biol Chem200427919201782018510.1074/jbc.M31292120014973128
   PubMedGoogle Scholar
• XuHLTanHNWangFSTangWResearch advances of endostatin and its short internal fragmentsCurr Protein Pept Sci20089327528318537682
   PubMedGoogle Scholar
• YuYSunFZhangCWangZLiuJTanHStudy on glycomodification of endostatin-derived synthetic peptide endostatin2 (ES2) by soluble chitooligosaccharideCarbohydr Polym201615420421310.1016/j.carbpol.2016.08.04327577911
   PubMedGoogle Scholar
• OhEJChoiJSKimHJooCKHahnSKAnti-Flt1 peptide – hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathyBiomaterials201132113115312310.1016/j.biomaterials.2011.01.00321277020
   PubMed Web of Science ®Google Scholar
• PasutGVeroneseFMState of the art in PEGylation: the great versatility achieved after forty years of researchJ Control Release2012161246147210.1016/j.jconrel.2011.10.03722094104
   PubMed Web of Science ®Google Scholar
• SchumacherDHackenbergerCPMore than add-on: chemoselective reactions for the synthesis of functional peptides and proteinsCurr Opin Chem Biol201422626910.1016/j.cbpa.2014.09.01825285752
   PubMedGoogle Scholar
• SuganumaTInoKShibataKFunctional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal disseminationClin Cancer Res20051172686269410.1158/1078-0432.CCR-04-194615814650
   PubMed Web of Science ®Google Scholar
• ArmstrongJKHempelGKolingSAntibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patientsCancer2007110110311110.1002/cncr.2273917516438
   PubMed Web of Science ®Google Scholar
• SlevinMKrupinskiJGaffneyJHyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathwaysMatrix Biol2007261586810.1016/j.matbio.2006.08.26117055233
   PubMedGoogle Scholar
• SternRAsariAASugaharaKNHyaluronan fragments: an information-rich systemEur J Cell Biol200685869971510.1016/j.ejcb.2006.05.00916822580
   PubMed Web of Science ®Google Scholar
• OhEJParkKChoiJSJooCKHahnSKSynthesis, characterization, and preliminary assessment of anti-Flt1 peptide-hyaluronate conjugate for the treatment of corneal neovascularizationBiomaterials200930306026603410.1016/j.biomaterials.2009.07.02419647313
   PubMedGoogle Scholar
• SunFYuYYangZHyaluronic acid-endostatin2-alft1 (HA-ES2-AF) nanoparticle-like conjugate for the target treatment of diseasesJ Control Release201828811310.1016/j.jconrel.2018.08.03830170067
   PubMed Web of Science ®Google Scholar
• ChenFFLiuYWangFEffects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicityCancer Gene Ther201522943143710.1038/cgt.2015.3826384138
   PubMedGoogle Scholar
• KimHChoiJSKimKSYangJAJooCKHahnSKFlt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularizationActa Biomater20128113932394010.1016/j.actbio.2012.07.01622824530
   PubMed Web of Science ®Google Scholar
• HuangXYZhangXMChenFHAnti-proliferative effect of recombinant human endostatin on synovial fibroblasts in rats with adjuvant arthritisEur J Pharmacol201472371410.1016/j.ejphar.2013.10.06824239715
   PubMed Web of Science ®Google Scholar
• LiangDSSuHTLiuYJWangATQiXRTumor-specific penetrating peptides-functionalized hyaluronic acid-d-alpha-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancersBiomaterials201571112310.1016/j.biomaterials.2015.08.03526310359
   PubMed Web of Science ®Google Scholar
• BaiYZhaoMZhangCAnti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularizationPLoS One2014911e11244810.1371/journal.pone.011244825380141
   PubMedGoogle Scholar
• XuXMaoWChenQEndostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/beta-catenin signaling pathwayPLoS One201499e10746310.1371/journal.pone.010746325232946
   PubMed Web of Science ®Google Scholar
• BaiYJHuangLZZhouAYZhaoMYuWZLiXXAntiangiogenesis effects of endostatin in retinal neovascularizationJ Ocul Pharmacol Ther201329761962610.1089/jop.2012.022523545016
   PubMedGoogle Scholar
• WangFBaiYYuWAnti-angiogenic effect of KH902 on retinal neovascularizationGraefes Arch Clin Exp Ophthalmol201325192131213910.1007/s00417-013-2392-623740520
   PubMedGoogle Scholar
• YuWZLiXXSheHCGene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularizationOphthalmic Res200335523924610.1159/00007214312920335
   PubMedGoogle Scholar
• QiuZHuJXuHWangWNieCWangXGeneration of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragmentAnticancer Drugs201324767768910.1097/CAD.0b013e328361b7ad23652276
   PubMedGoogle Scholar
• RenZWangYJiangWDaiWJiangYAnti-tumor effect of a novel soluble recombinant human endostatin: administered as a single agent or in combination with chemotherapy agents in mouse tumor modelsPLoS One201499e10782310.1371/journal.pone.010782325229620
   PubMed Web of Science ®Google Scholar
• GuoLSongNHeTEndostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1Mol Carcinog201554111340135310.1002/mc.2221025175281
   PubMedGoogle Scholar
• RooneyPKumarSPontingJWangMThe role of hyaluronan in tumour neovascularization (review)Int J Cancer19956056326367532158
   PubMedGoogle Scholar
• LiuLKFinzelBCFragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitorsJ Med Chem20145762714272510.1021/jm500027624606063
   PubMed Web of Science ®Google Scholar
• ParkKCChoiSHEffects of endostatin and a new drug terpestacin against human neuroblastoma xenograft and cell linesPediatr Surg Int201329121327134010.1007/s00383-013-3398-124072200
   PubMedGoogle Scholar
• YingTPrabakaranPDuLJunctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibodyNat Commun20156822310.1038/ncomms922326370782
   PubMed Web of Science ®Google Scholar
• OhEJParkKKimKSTarget specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivativesJ Control Release2010141121210.1016/j.jconrel.2009.09.01019758573
   PubMed Web of Science ®Google Scholar
• YangJAKongWHSungDKHyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosisActa Biomater20151217418210.1016/j.actbio.2014.10.00225305513
   PubMed Web of Science ®Google Scholar
• ZhangPJainPTsaoCButyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune responseJ Control Release2016230737810.1016/j.jconrel.2016.04.00827063423
   PubMed Web of Science ®Google Scholar
• LinXWangSJiangYPoly(ethylene glycol)-Radix ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivityEur J Pharm Biopharm20107623023710.1016/j.ejpb.2010.07.00320633648
   PubMed Web of Science ®Google Scholar
• PangXYangXZhaiGPolymer-drug conjugates: recent progress on administration routesExpert Opin Drug Deliv20141171075108610.1517/17425247.2014.91277924758250
   PubMed Web of Science ®Google Scholar
• Pelegri-O’dayEMLinEWMaynardHDTherapeutic protein-polymer conjugates: advancing beyond PEGylationJ Am Chem Soc201413641143231433210.1021/ja504390x25216406
   PubMed Web of Science ®Google Scholar
• SaravanakumarGDeepaganVGJayakumarRParkJHHyaluronic acid-based conjugates for tumor-targeted drug delivery and imagingJ Biomed Nanotechnol2014101173124724496
   PubMed Web of Science ®Google Scholar
• WestDCKumarSThe effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrityExp Cell Res198918311791962472284
   PubMedGoogle Scholar
• NguyenHHParkJKangSKimMSurface plasmon resonance: a versatile technique for biosensor applicationsSensors (Basel)2015155104811051010.3390/s15051048125951336
   PubMed Web of Science ®Google Scholar
• KimYMHwangSKimYMEndostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1J Biol Chem200227731278722787910.1074/jbc.M20277120012029087
   PubMed Web of Science ®Google Scholar
• ShiHHuangYZhouHNucleolin is a receptor that mediates anti-angiogenic and anti-tumor activity of endostatinBlood200711082899290610.1182/blood-2007-01-06442817615292
   PubMedGoogle Scholar
• TanHYangSFengYCharacterization and secondary structure analysis of endostatin covalently modified by polyethylene glycol and low molecular weight heparinJ Biochem2008144220721310.1093/jb/mvn06018463113
   PubMedGoogle Scholar
• LeeSJJangJWKimYMEndostatin binds to the catalytic domain of matrix metalloproteinase-2FEBS Lett20025191–314715212023034
   PubMedGoogle Scholar
• WightTNKinsellaMGQwarnströmEEThe role of proteoglycans in cell adhesion, migration and proliferationCurr Opin Cell Biol1992479380110.1016/0955-0674(92)90102-I1419056
   PubMedGoogle Scholar
• KleinmanHKMartinGRMatrigel: basement membrane matrix with biological activitySemin Cancer Biol200515537838610.1016/j.semcancer.2005.05.00415975825
   PubMed Web of Science ®Google Scholar
• MondrinosMJKoutzakiSJiwanmallEEngineering three-dimensional pulmonary tissue constructsNeuroimage2006124717728
   Google Scholar
• WickstromSAVeikkolaTRehnMEndostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesion and actin stess fibers in cultured human endothelial cellsCancer Res200161176511651611522648
   PubMedGoogle Scholar
• LeeWSPyunBJKimSWTTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesisMabs20157595796810.1080/19420862.2015.104516825942475
   PubMed Web of Science ®Google Scholar
• ZhaoHChenZScreening of neuraminidase inhibitors from traditional Chinese medicines by integrating capillary electrophoresis with immobilized enzyme microreactorJ Chromatogr A20141340813914510.1016/j.chroma.2014.03.02824679826
   PubMedGoogle Scholar
• IshidaTImmunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinomaSurg Today2000301283210.1007/PL0001004210648079
   PubMedGoogle Scholar
• WangCXieJGuoJManningHCGoreJCGuoNEvaluation of CD44 and CD133 as cancer stem cell markers for colorectal, cancerOncol Rep20122841301130810.3892/or.2012.195122895640
   PubMedGoogle Scholar
• PietrasAKatzAMEkströmEJOsteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growthCell Stem Cell201414335736910.1016/j.stem.2014.01.00524607407
   PubMed Web of Science ®Google Scholar
• BernerHSSuoZRisbergBVillmanKKarlssonMGNeslandJMClinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomasHistopathology200342654655412786890
   PubMedGoogle Scholar
• DiazLKZhouXWrightETCD44 expression is associated with increased survival in node-negative invasive breast carcinomaBreast Dis2006164359
   Google Scholar
• HermannPCHuberSLHerrlerTDistinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancerCell Stem Cell20071331332310.1016/j.stem.2007.06.00218371365
   PubMed Web of Science ®Google Scholar
• LiCLeeCJSimeoneDMIdentification of human pancreatic cancer stem cellsMethods Mol Biol200956816117310.1007/978-1-59745-280-9_1019582426
   PubMedGoogle Scholar
• SetchellKDZhaoXHJhaPHeubiJEBrownNMThe pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracersAm J Clin Nutr2009901029103710.3945/ajcn.2009.2798119710188
   PubMed Web of Science ®Google Scholar
• ZhuYD’ArienzoCLouZLC-MS/MS multiplexed assay for the quantitation of a therapeutic protein BMS-986089 and the target protein MyostatinBioanalysis20168319320410.4155/bio.15.23826811930
   PubMedGoogle Scholar
• JenkinsRDugganJXAubryAFRecommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeuticsAaps J201517111610.1208/s12248-014-9685-525392238
   PubMed Web of Science ®Google Scholar